1. Home
  2. SRDX vs MAGN Comparison

SRDX vs MAGN Comparison

Compare SRDX & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • MAGN
  • Stock Information
  • Founded
  • SRDX 1979
  • MAGN 1864
  • Country
  • SRDX United States
  • MAGN United States
  • Employees
  • SRDX N/A
  • MAGN N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • MAGN Paper
  • Sector
  • SRDX Health Care
  • MAGN Basic Materials
  • Exchange
  • SRDX Nasdaq
  • MAGN Nasdaq
  • Market Cap
  • SRDX 415.4M
  • MAGN 442.9M
  • IPO Year
  • SRDX 1998
  • MAGN N/A
  • Fundamental
  • Price
  • SRDX $30.91
  • MAGN $13.28
  • Analyst Decision
  • SRDX Buy
  • MAGN Hold
  • Analyst Count
  • SRDX 2
  • MAGN 1
  • Target Price
  • SRDX $43.00
  • MAGN $16.00
  • AVG Volume (30 Days)
  • SRDX 92.6K
  • MAGN 951.1K
  • Earning Date
  • SRDX 07-30-2025
  • MAGN 08-15-2025
  • Dividend Yield
  • SRDX N/A
  • MAGN N/A
  • EPS Growth
  • SRDX N/A
  • MAGN N/A
  • EPS
  • SRDX N/A
  • MAGN N/A
  • Revenue
  • SRDX $121,575,000.00
  • MAGN $2,636,000,000.00
  • Revenue This Year
  • SRDX N/A
  • MAGN $47.87
  • Revenue Next Year
  • SRDX $3.70
  • MAGN $4.76
  • P/E Ratio
  • SRDX N/A
  • MAGN N/A
  • Revenue Growth
  • SRDX N/A
  • MAGN 15.87
  • 52 Week Low
  • SRDX $26.00
  • MAGN $11.43
  • 52 Week High
  • SRDX $42.25
  • MAGN $26.78
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 65.27
  • MAGN N/A
  • Support Level
  • SRDX $29.51
  • MAGN N/A
  • Resistance Level
  • SRDX $31.06
  • MAGN N/A
  • Average True Range (ATR)
  • SRDX 0.91
  • MAGN 0.00
  • MACD
  • SRDX 0.18
  • MAGN 0.00
  • Stochastic Oscillator
  • SRDX 86.61
  • MAGN 0.00

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

Share on Social Networks: